Hulio 40 mg (Adalimumab SOLUTION) 40 MG

HULIO 40 MG is a subcutaneous solution containing adalimumab, a biosimilar medication used for managing inflammatory conditions. Learn about its uses, effects, and precautions.

Strength

40 MG

Manufacturer / TM Owner

BIOSIMILAR COLLABORATIONS IRELAND LIMITED

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

HULIO 40 MG is primarily used for the treatment of inflammatory conditions such as rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. This medication works by targeting specific proteins in the body to reduce inflammation and alleviate symptoms. Patients often wonder, 'What is HULIO 40 MG used for?' It is commonly prescribed to manage pain and improve mobility in conditions involving joint inflammation.

Side Effects

Common effects of HULIO 40 MG may include injection site reactions, such as redness, swelling, or itching. Some users might experience mild to moderate fatigue or headache. These effects are generally temporary and may subside as the body adjusts to the medication. Always consult a healthcare provider for personalized advice.

Precautions & Warnings

HULIO 40 MG should be stored at room temperature and protected from light. It is important to follow proper subcutaneous injection techniques to minimize the risk of infection. Patients with a history of severe allergic reactions to adalimumab or similar medications should avoid using this solution. Always handle the medication with clean hands and dispose of used needles safely.

Avoid Interactions

HULIO 40 MG may interact with other medications, including those that suppress the immune system. Alcohol consumption should be moderated, as it can increase the risk of side effects. Patients taking CYP inhibitors or other immunosuppressive drugs should discuss potential interactions with their healthcare provider before starting HULIO 40 MG.

Frequently Asked Questions

HULIO 40 MG is used to manage inflammatory conditions like rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis.

HULIO 40 MG is administered via subcutaneous injection, typically into the thigh, abdomen, or upper arm.

Common side effects include injection site reactions, fatigue, and headache.

HULIO 40 MG may interact with other medications, especially those that suppress the immune system.

HULIO 40 MG should be stored at room temperature and protected from light.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.